- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07274423
Clinical Value of Deep Learning Reconstruction Technology in Ankle MRI
November 27, 2025 updated by: Lian Yang
By enrolling patients who underwent ankle MR(Magnetic Resonance) examinations at our center and using randomized allocation, the patients were divided into a study group and a control group.
The study group underwent scanning using AI-based(Artificial Intelligence-based) ankle MRI sequences, while the control group was scanned using non-AI ankle MRI sequences.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
120
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lian Yang
- Phone Number: 18986273791
- Email: yanglian@hust.edu.cn
Study Locations
-
-
Hubei
-
Wuhan, Hubei, China, 430000
- Recruiting
- Union Hospital,Tongji Medical College,Huazhong University of Science and Technology
-
Contact:
- Lian Yang
- Phone Number: 18986273791
- Email: yanglian@hust.edu.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
patients with a clear history of ankle trauma
Description
Inclusion Criteria:
- Patients undergoing ankle MRI at Wuhan Union Hospital from August 2025 to August 2026;
- Aged > 18 years old;
- Patients who agree to participate in the study and provide signed informed consent;
- Presence of a clear history of ankle trauma and related symptoms requiring MRI for diagnosis or evaluation.
Exclusion Criteria:
1 .Patients with MR examination contraindications (e.g., implanted metal devices or severe claustrophobia); 2. Patients with prior ankle surgery; 3. Patients who failed to complete MR examination or whose image quality was insufficient for diagnostic purposes.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
scanning using AI-based ankle MRI sequences
|
|
scanned using non-AI ankle MRI sequences
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient satisfaction
Time Frame: immediately after procedure
|
Patient satisfaction will be evaluated using a Likert scale with the following scoring criteria:5 - Very Satisfied;4 - Satisfied;3 - Neutral;2 - Dissatisfied;1 - Very Dissatisfied.
|
immediately after procedure
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
total scan time
Time Frame: During procedure
|
During procedure
|
|
objective image measurements (signal-to-noise ratio)
Time Frame: one week
|
one week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2025
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 1, 2026
Study Registration Dates
First Submitted
November 19, 2025
First Submitted That Met QC Criteria
November 27, 2025
First Posted (Actual)
December 10, 2025
Study Record Updates
Last Update Posted (Actual)
December 10, 2025
Last Update Submitted That Met QC Criteria
November 27, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- 2025-0802
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ankle Trauma
-
Pharmanutra S.p.a.NEA Clinical S.r.l.Active, not recruitingAnkle Injury or Chronic Trauma to the AnkleGeorgia, Italy
-
University of OuluCompleted
-
University of OuluCompleted
-
University of OuluSuspended
-
J L MarshUniversity of Washington; University of Kansas Medical Center; University of... and other collaboratorsCompletedPost-traumatic Osteoarthritis | Trauma | Orthopedic Disorder | Ankle FracturesUnited States
-
Rothman Institute OrthopaedicsCompletedTrauma Injury | Ankle Fractures
-
University Hospital, LilleTerminated
-
Susanne BeischerUmeå UniversityCompletedAnkle Injuries | Overuse Injury | Ankle Sprains | Foot InjurySweden
-
Second Affiliated Hospital, School of Medicine,...RecruitingAnkle Ligament Injury,Chronic Ankle Instability,Ankle ArthroscopyChina